Harbor Capital Advisors’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$103K	Buy	15,277 +1,874	+14%	+$12.6K	﹤0.01%	647
2025 Q1	$121K	Buy	+13,403	New	+$121K	0.01%	645
2024 Q2	–	Sell	-14,543	Closed	-$206K	–	771
2024 Q1	$206K	Buy	+14,543	New	+$206K	0.03%	593